SOHO Highlights: State of the Art and Next Questions

 

SOHO Highlights: State of the Art and Next Questions
K

Newly Diagnosed ALCL/PTCL State of the Art: How Can We Improve Outcomes in PTCL? Does 1L Brentuximab Vedotin Improve PFS? Is Consolidative SCT Beneficial?

By SOHO Highlights: State of the Art and Next Questions FEATURING Kerry Savage
By SOHO Highlights: State of the Art and Next Questions FEATURING Kerry Savage
129 views
February 3, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
2021
14:40

Newly Diagnosed ALCL/PTCL State of the Art: How Can We Improve Outco…

SOHO Highlights: State of the Art and Next Questions

K. Savage

129 views
13:36

SOHO Updates on 1L FL: Does RT+/-(R)CVP Improve PFS in Limited Stage…

SOHO Highlights: State of the Art and Next Questions

R. Marcus

117 views
14:42

SOHO Highlights on Non-Bulky cHL: Can We Treat Early Disease With Sh…

SOHO Highlights: State of the Art and Next Questions

D. Straus

23 views
09:24

ECHELON-1 Data on Brentuximab Vedotin for Frontline Advanced cHL: Ex…

SOHO Highlights: State of the Art and Next Questions

D. Straus

292 views
10:47

Surveying the Induction and Maintenance Therapy Landscape in Newly D…

SOHO Highlights: State of the Art and Next Questions

S. Lonial

243 views
20:52

MM State of the Art: Approaches to Smoldering, MRD as a Prognostic M…

SOHO Highlights: State of the Art and Next Questions

S. Lonial

34 views
29:37

CML State of the Art: Dasatinib/Imatinib Dose Optimization, STAMPi A…

SOHO Highlights: State of the Art and Next Questions

M. Deininger

62 views
34:50

MPNs State of the Art: What Is the Response to Ruxolitinib vs. BAT? …

SOHO Highlights: State of the Art and Next Questions

S. Verstovsek

166 views
27:43

MDS State of the Art: Imetelstat/Roxadustat for Anemia, Oral HMAs, A…

SOHO Highlights: State of the Art and Next Questions

G. Garcia-Manero

131 views
11:39

Early Stage cHL Management: Bulky vs. Non-bulky Disease, Better Chem…

SOHO Highlights: State of the Art and Next Questions

D. Straus

174 views
14:25

SOHO Highlights on Untreated MCL: How Does Deferred Therapy Work? Wh…

SOHO Highlights: State of the Art and Next Questions

J. Cohen

95 views
19:43

SOHO Highlights on R/R MCL: The Role of BTKis, CAR-T, and Chemothera…

SOHO Highlights: State of the Art and Next Questions

J. Cohen

156 views
20:07

R/R PTCL State of the Art: Allo-SCT vs. Auto-SCT? Can Pralatrexate C…

SOHO Highlights: State of the Art and Next Questions

K. Savage

23 views
18:07

SOHO Updates on 1L MZL: Can RT Help in Early Stage MALToma? Is R-Ben…

SOHO Highlights: State of the Art and Next Questions

R. Marcus

19 views
34:46

DLBCL State of the Art: Does Gene Expression Help With the Disease? …

SOHO Highlights: State of the Art and Next Questions

S. Dave

123 views
24:38

Dana-Farber CLL State of the Art: A Review of BTK Inhibitors Data in…

SOHO Highlights: State of the Art and Next Questions

J. Brown

227 views
24:52

CAR-T State of the Art: What Therapies Will Be Available in the Next…

SOHO Highlights: State of the Art and Next Questions

S. Giralt

40 views
29:51

AML State of the Art: Older Patients Management, MRD, Total Oral Com…

SOHO Highlights: State of the Art and Next Questions

A. Zeidan

124 views
29:28

ALL State of the Art at MD Anderson: Hyper-CVAD Combinations, MiniHC…

SOHO Highlights: State of the Art and Next Questions

H. Kantarjian

39 views